Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 150,425 | 144,121 | 125,563 | 122,311 | 137,142 |
| Marketable Securities | 0 | 1,966 | 3,499 | 5,048 | 6,338 |
| Receivables | 63,450 | 83,659 | 73,482 | 64,399 | 35,942 |
| Inventories | 17,319 | 14,661 | 17,979 | 17,262 | 22,163 |
| Income taxes - deferred | 441 | 1,735 | 7,209 | 7,082 | 6,743 |
| TOTAL | $239,542 | $254,418 | $236,765 | $223,844 | $216,203 |
| Non-Current Assets | |||||
| PPE Net | 218,749 | 208,973 | 188,245 | 172,481 | 157,963 |
| Intangibles | 5,502 | 5,502 | 5,502 | 5,029 | 5,029 |
| Other Non-Current Assets | 50,894 | 77,971 | 82,450 | 92,630 | 92,082 |
| TOTAL | $275,145 | $292,446 | $276,197 | $270,140 | $255,074 |
| Total Assets | $514,687 | $546,864 | $512,962 | $493,984 | $471,277 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,280 | 5,360 | 4,920 | 10,229 | 16,927 |
| Accounts payable and accrued liabilities | 28,316 | 40,530 | 33,902 | 32,182 | 24,034 |
| Accrued Expenses | 11,116 | 22,054 | 15,885 | 15,023 | 14,944 |
| Other current liabilities | 0 | 1,748 | 9,865 | 9,734 | 9,113 |
| TOTAL | $42,995 | $71,054 | $68,931 | $72,504 | $70,934 |
| Non-Current Liabilities | |||||
| Long Term Debt | 57,592 | 54,094 | 48,873 | 29,074 | 29,657 |
| Deferred Revenues | 283 | 1,362 | 4,359 | 5,336 | 5,916 |
| Other Non-Current Liabilities | 3,198 | 6,746 | 9,560 | 9,910 | 9,716 |
| TOTAL | $59,597 | $59,083 | $59,528 | $40,250 | $41,420 |
| Total Liabilities | $102,592 | $130,137 | $128,459 | $112,754 | $112,354 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,161 | 36,015 | 35,953 | 35,851 | 35,508 |
| Common Shares | 36 | 36 | 36 | 36 | 35 |
| Retained earnings | 190,041 | 196,869 | 168,212 | 166,663 | 152,453 |
| Other shareholders' equity | -728 | -832 | 317 | 1,211 | 2,068 |
| TOTAL | $412,095 | $416,727 | $384,503 | $381,230 | $358,923 |
| Total Liabilities And Equity | $514,687 | $546,864 | $512,962 | $493,984 | $471,277 |